Recent advances in the genomics and therapy of BCR/ABL1-positive and -negative chronic myeloproliferative neoplasms.

MLA

Mughal, Tariq I., et al. “Recent Advances in the Genomics and Therapy of BCR/ABL1-Positive and -Negative Chronic Myeloproliferative Neoplasms.” Leukemia Research, vol. 67, Apr. 2018, pp. 67–74. EBSCOhost, https://doi.org/10.1016/j.leukres.2018.02.008.

APA

Mughal, T. I., Gotlib, J., Mesa, R., Koschmieder, S., Khoury, H. J., Cortes, J. E., Barbui, T., Hehlmann, R., Mauro, M., Saussele, S., Radich, J. P., Van Etten, R. A., Saglio, G., Verstovek, S., Gale, R. P., & Abdel-Wahab, O. (2018). Recent advances in the genomics and therapy of BCR/ABL1-positive and -negative chronic myeloproliferative neoplasms. Leukemia Research, 67, 67–74. https://doi.org/10.1016/j.leukres.2018.02.008

Chicago

Mughal, Tariq I, Jason Gotlib, Ruben Mesa, Steffen Koschmieder, H Jean Khoury, Jorge E Cortes, Tiziano Barbui, et al. 2018. “Recent Advances in the Genomics and Therapy of BCR/ABL1-Positive and -Negative Chronic Myeloproliferative Neoplasms.” Leukemia Research 67 (April): 67–74. doi:10.1016/j.leukres.2018.02.008.